
### [NCIT:C134604](http://purl.obolibrary.org/obo/NCIT_C134604)
**Label:** Intrahepatic Bile Duct Cancer by AJCC v8 Stage

**Subclasses:** [NCIT:C134761](http://purl.obolibrary.org/obo/NCIT_C134761) (Stage III Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134760](http://purl.obolibrary.org/obo/NCIT_C134760) (Stage II Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134756](http://purl.obolibrary.org/obo/NCIT_C134756) (Stage 0 Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134755](http://purl.obolibrary.org/obo/NCIT_C134755) (Intrahepatic Cholangiocarcinoma by AJCC v8 Stage), [NCIT:C134610](http://purl.obolibrary.org/obo/NCIT_C134610) (Stage I Intrahepatic Bile Duct Cancer AJCC v8), [NCIT:C134764](http://purl.obolibrary.org/obo/NCIT_C134764) (Stage IV Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134615](http://purl.obolibrary.org/obo/NCIT_C134615) (Stage III Intrahepatic Bile Duct Cancer AJCC v8), [NCIT:C134614](http://purl.obolibrary.org/obo/NCIT_C134614) (Stage II Intrahepatic Bile Duct Cancer AJCC v8), [NCIT:C134757](http://purl.obolibrary.org/obo/NCIT_C134757) (Stage I Intrahepatic Cholangiocarcinoma AJCC v8), [NCIT:C134609](http://purl.obolibrary.org/obo/NCIT_C134609) (Stage 0 Intrahepatic Bile Duct Cancer AJCC v8), [NCIT:C134619](http://purl.obolibrary.org/obo/NCIT_C134619) (Stage IV Intrahepatic Bile Duct Cancer AJCC v8), 

**Class expressions from DL-Learner:**

- [NCIT:C132248](http://purl.obolibrary.org/obo/NCIT_C132248) (AJCC v8 Stage) 66.67%
- [CL:0000417](http://purl.obolibrary.org/obo/CL_0000417) (endopolyploid cell) 66.67%
- [CL:0000412](http://purl.obolibrary.org/obo/CL_0000412) (polyploid cell) 66.67%
- [CL:0000182](http://purl.obolibrary.org/obo/CL_0000182) (hepatocyte) 66.67%
- [CL:0000181](http://purl.obolibrary.org/obo/CL_0000181) (metabolising cell) 66.67%
- Thing 51.13%
- [UBERON:0003704](http://purl.obolibrary.org/obo/UBERON_0003704) (intrahepatic bile duct) 45.53%
- [BFO:0000002](http://purl.obolibrary.org/obo/BFO_0000002) (null) 34.78%
- [NCIT:C28108](http://purl.obolibrary.org/obo/NCIT_C28108) (Disease Stage Qualifier) 31.10%
- [NCIT:C41009](http://purl.obolibrary.org/obo/NCIT_C41009) (Qualifier) 28.45%
- [NCIT:C27992](http://purl.obolibrary.org/obo/NCIT_C27992) (Disease Qualifier) 28.45%
- [NCIT:C20189](http://purl.obolibrary.org/obo/NCIT_C20189) (Property or Attribute) 28.45%
- [CL:0002371](http://purl.obolibrary.org/obo/CL_0002371) (somatic cell) 19.72%
- [CL:0000255](http://purl.obolibrary.org/obo/CL_0000255) (eukaryotic cell) 19.64%
- [CL:0000003](http://purl.obolibrary.org/obo/CL_0000003) (native cell) 19.43%


